G
GenFlow
Organization
A biotechnology company developing gene-therapy and longevity programs, including work involving SIRT6 and age-related diseases.
What experts have said about GenFlow
2 statements · 1 positive · 1 neutral
GenFlow intends to license human programs after Phase 2 efficacy signals.
“our model is to license at Phase 2.”
Open the episode · S12 Ep2: The Sunday Roast featuring Genflow Biosciences, Energy Pathways and Buccaneer Energy #GENF #EPP #BUCE #INC #KEN #FMET #GMET #SVML #UOG #TGR #TAR #XTR #AFP #SRVLListen at 44:41
GenFlow expects business-development proceeds to advance three human programs.
“Getting these trade sales or business development deal will definitely allow us to move our programs, our 3 programs in humans: glaucoma, MASH, and sarcopenia.”
Open the episode · S12 Ep2: The Sunday Roast featuring Genflow Biosciences, Energy Pathways and Buccaneer Energy #GENF #EPP #BUCE #INC #KEN #FMET #GMET #SVML #UOG #TGR #TAR #XTR #AFP #SRVLListen at 45:05
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
